This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Litigation & Arbitration,
Ediscovery

Oct. 31, 2022

Discovery path cleared for new claims against McKinsey

U.S. District Judge Charles Breyer Breyer rejected the advertising company’s motion to dismiss claims by local governments, school districts and tribes from 19 states and set the discovery calendar in a group of orders issued in San Francisco. The company also has a pending motion that the claims were already settled in a $573 million agreement with 47 states in 2021.

U.S. District Judge Charles Breyer has cleared the path for discovery in the multidistrict litigation against McKinsey and Co. in which it is accused of a predatory OxyContin marketing scheme.

Breyer rejected the company’s motion to dismiss claims by local governments, school districts and tribes from 19 states, and scheduled the discovery calendar in a group of orders issued Thursday in San Francisco.

A separa...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up